We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Mosquito Mesh Could Help Raise Herniorrhaphy Rates

By HospiMedica International staff writers
Posted on 23 Sep 2015
A new doctoral thesis suggests that inexpensive mosquito mesh could be used as a safe alternative for groin hernia surgery in lower income countries. More...


A collaboration of researchers at Umea University (Sweden), Karolinska Institutet (KI, Solna, Sweden), and Makerere University (Kampala, Uganda) conducted three studies in the Iganga and Mayuge districts of eastern Uganda in order to define the prevalence of groin hernia; relate it to the surgical capacity, outcomes, and costs of surgery; and investigate the feasibility and difference in cost and cost-effectiveness of replacing a commercial mesh with a mosquito mesh in groin hernia surgery via a double blinded, randomized controlled trial.

The results showed that the prevalence of untreated groin hernia among the study participants was 6.6%, and that that the rate of groin hernia surgery was 17 per 100,000 of the general population, meaning that less than 1% of the estimated number of groin hernia sufferers is operated on per year. The third study found no significant differences in recurrence rates, postoperative and chronic complications, and patient satisfaction among the 300 patients operated using the mosquito mesh, compared to commercial mesh.

“Mosquito mesh with the purpose of catching mosquitoes can now be used to prevent the intestines from falling through the hole in the abdominal wall,” said doctoral dissertant Jenny Löfgren, of the department of surgical and perioperative sciences at Umea University. “A superior surgical method can also be provided for poor patients at a fraction of the cost of the expensive mesh. These findings may benefit the many millions of groin hernia patients living in low and middle income countries.”

Herniorrhaphy is one of the most commonly performed surgical procedures worldwide. But while 200 million people suffer annually from groin hernias, only 20 million herniorrhaphies are carried out in low and middle income countries (LMIC) annually due to financial constraints. Mosquito mesh is much cheaper, despite being very similar to commercial meshes, reducing the cost of surgery by USD 124.

Related Links:

Umea University
Karolinska Institutet
Makerere University 



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.